VeriFax is an R&D enterprise with the main mission to develop high quality, cost effective security and biomedical devices. The firm also has a subsiduary designated Neuroskill. The biomedical device “Neuroskill" is designed to assess fine motor control fluctuations in people with neurological disorders, such as Parkinson's disease and stroke, while Impairscope is a device to assess impairment due to environmental intoxication and result of substance abuse. The measures of impairment provided by Neuroskill and Impairscope can be considered as potential clinical markers for prospective applications. The biometric device Autograph offers an easy, cost-effective and universally accepted solution for signature verification with unprecedented accuracy. It can be used in both cyber security and physical security.
